Oncology
Harbinger Health secures $140m funding for cancer screening platform study
Harbinger Health has raised $140m in a Series B funding round, which will enable the completion of the study of…
US FDA grants clearance for Profound’s Thermal Boost module
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Profound Medical’s Thermal Boost module for use along…
Galvanize Therapeutics commences Aliya PEF System trial
Galvanize Therapeutics has commenced the AFFINITY clinical study in the US to assess the safety and technical success of the…
Broncus Medical launches new transbronchial needle
Broncus Medical has introduced the new BioStar Transbronchial Aspiration Needle (TBNA) for minimally invasive diagnostic applications. Medical professionals can use…
Novocure’s tumour-treating electric fields fall short in ovarian cancer trial
Novocure’s tumour treating fields (TTFields) failed to recreate its efficacy in previous cancer studies, after the company announced that the…
BioProtect secures FDA approval for biodegradable balloon
Israel-based medical device company BioProtect has secured approval from the US Food and Drug Administration (FDA) for its new biodegradable…
Boston Scientific secures expanded FDA clearance for cryoablation system
Boston Scientific is continuing its cryoablation market push, as the company secured another US Food and Drug Administration (FDA) win…
Tempus’ tumorigenesis diagnostic test secures FDA breakthrough
A companion test from Tempus that uses machine learning to identify solid tumours with an allelic imbalance has secured breakthrough…
Telix doses first Chinese patient in prostate cancer imaging study
Telix has dosed the first Chinese patient in the pivotal Phase III registration trial of TLX591-CDx (Illuccix), a kit designed…
DermaSensor’s skin cancer detection device works on different skin tones
A sub-analysis in a recent study by DermaSensor has demonstrated that its skin cancer detection device can reliably detect cancers…